MedPath

OncoSynergy, Inc.

OncoSynergy, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2011-01-01
Employees
1
Market Cap
-
Website
http://www.oncosynergy.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection

Phase 1
Terminated
Conditions
High Grade Glioma
Glioblastoma
Glioblastoma Multiforme
Glioma, Malignant
Anaplastic Astrocytoma
Interventions
First Posted Date
2020-10-29
Last Posted Date
2023-08-18
Lead Sponsor
OncoSynergy, Inc.
Target Recruit Count
7
Registration Number
NCT04608812
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.